Search filters

List of works by Valentina Marchica

Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories

scientific article published on 6 March 2017

Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients

scientific article published on 06 March 2019

Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma.

scientific article

Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?

scientific article published on 3 October 2016

Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target.

scientific article published on 6 June 2016

Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation

scientific article published on 16 May 2017

Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo

scientific article published on 17 June 2016

IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts.

scientific article

ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma

scientific article published on 9 June 2017

Neurofibromatosis type I and multiple myeloma coexistence: A possible link?

scientific article

Novel targets for the treatment of relapsing multiple myeloma

scientific article published on 03 June 2019

Possible targets to treat myeloma-related osteoclastogenesis.

scientific article published on 2 March 2018

Role of Galectins in Multiple Myeloma

scientific article published on 17 December 2017

The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors

scientific article published on 9 November 2015

The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells.

scientific article published on 11 December 2015

The transcriptomic profile of CD138+ cells from patients with early progression from smoldering to active multiple myeloma remains substantially unchanged

scientific article published on 07 March 2019